Literature DB >> 27211075

DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops.

Bas van der Woning1, Gitte De Boeck1, Christophe Blanchetot1, Vladimir Bobkov1,2, Alex Klarenbeek3, Michael Saunders1, Magali Waelbroeck4, Toon Laeremans5, Jan Steyaert5,6, Anna Hultberg1, Hans De Haard1.   

Abstract

The identification of functional monoclonal antibodies directed against G-protein coupled receptors (GPCRs) is challenging because of the membrane-embedded topology of these molecules. Here, we report the successful combination of llama DNA immunization with scFv-phage display and selections using virus-like particles (VLP) and the recombinant extracellular domain of the GPCR glucagon receptor (GCGR), resulting in glucagon receptor-specific antagonistic antibodies. By immunizing outbred llamas with plasmid DNA containing the human GCGR gene, we sought to provoke their immune system, which generated a high IgG1 response. Phage selections on VLPs allowed the identification of mAbs against the extracellular loop regions (ECL) of GCGR, in addition to multiple VH families interacting with the extracellular domain (ECD) of GCGR. Identifying mAbs binding to the ECL regions of GCGR is challenging because the large ECD covers the small ECLs in the energetically most favorable 'closed conformation' of GCGR. Comparison of Fab with scFv-phage display demonstrated that the multivalent nature of scFv display is essential for the identification of GCGR specific clones by selections on VLPs because of avid interaction. Ten different VH families that bound 5 different epitopes on the ECD of GCGR were derived from only 2 DNA-immunized llamas. Seven VH families demonstrated interference with glucagon-mediated cAMP increase. This combination of technologies proved applicable in identifying multiple functional binders in the class B GPCR context, suggesting it is a robust approach for tackling difficult membrane proteins.

Entities:  

Keywords:  DNA immunizations; glucagon receptor; llama; phage display; single-chain Fv; virus-like particles

Mesh:

Substances:

Year:  2016        PMID: 27211075      PMCID: PMC4968103          DOI: 10.1080/19420862.2016.1189050

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  24 in total

1.  A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies.

Authors:  H J de Haard; N van Neer; A Reurs; S E Hufton; R C Roovers; P Henderikx; A P de Bruïne; J W Arends; H R Hoogenboom
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

2.  Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection.

Authors:  Hans J W De Haard; Sandra Bezemer; Aat M Ledeboer; Wally H Müller; Piet J Boender; Sylvain Moineau; Marie-Cecile Coppelmans; Arie J Verkleij; Leon G J Frenken; C Theo Verrips
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

3.  Antibody humanization using monovalent phage display.

Authors:  M Baca; L G Presta; S J O'Connor; J A Wells
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

4.  Molecular basis for negative regulation of the glucagon receptor.

Authors:  Christopher M Koth; Jeremy M Murray; Susmith Mukund; Azadeh Madjidi; Alexandra Minn; Holly J Clarke; Terence Wong; Vicki Chiang; Elizabeth Luis; Alberto Estevez; Jesus Rondon; Yingnan Zhang; Isidro Hötzel; Bernard B Allan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

5.  Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment.

Authors:  Catherine J Hutchings; Gabriella Cseke; Greg Osborne; Jeanette Woolard; Andrei Zhukov; Markus Koglin; Ali Jazayeri; Jahnavi Pandya-Pathak; Christopher J Langmead; Stephen J Hill; Malcolm Weir; Fiona H Marshall
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

6.  A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).

Authors:  Ronald S Boshuizen; Catherine Marsden; Johan Turkstra; Christine J Rossant; Jerry Slootstra; Clive Copley; Klaus Schwamborn
Journal:  MAbs       Date:  2014       Impact factor: 5.857

7.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

8.  Human anti-self antibodies with high specificity from phage display libraries.

Authors:  A D Griffiths; M Malmqvist; J D Marks; J M Bye; M J Embleton; J McCafferty; M Baier; K P Holliger; B D Gorick; N C Hughes-Jones
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

9.  Mapping of human autoantibody binding sites on the calcium-sensing receptor.

Authors:  E Helen Kemp; Nikos G Gavalas; Samia Akhtar; Kai J E Krohn; J Carl Pallais; Edward M Brown; Philip F Watson; Anthony P Weetman
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

10.  Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.

Authors:  Urs B Hagemann; Lavinia Gunnarsson; Solène Géraudie; Ulrike Scheffler; Remko A Griep; Herald Reiersen; Alexander R Duncan; Sergej M Kiprijanov
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

View more
  9 in total

Review 1.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; William C Olson; Fiona H Marshall
Journal:  Nat Rev Drug Discov       Date:  2017-07-14       Impact factor: 84.694

2.  Conformational selection guides β-arrestin recruitment at a biased G protein-coupled receptor.

Authors:  Andrew B Kleist; Shawn Jenjak; Andrija Sente; Lauren J Laskowski; Martyna Szpakowska; Maggie M Calkins; Emilie I Anderson; Lisa M McNally; Raimond Heukers; Vladimir Bobkov; Francis C Peterson; Monica A Thomas; Andy Chevigné; Martine J Smit; John D McCorvy; M Madan Babu; Brian F Volkman
Journal:  Science       Date:  2022-07-07       Impact factor: 63.714

Review 3.  Improving antibody drug development using bionanotechnology.

Authors:  Emily K Makowski; John S Schardt; Peter M Tessier
Journal:  Curr Opin Biotechnol       Date:  2021-12-07       Impact factor: 10.279

4.  A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3.

Authors:  Janna Bednenko; Rian Harriman; Lore Mariën; Hai M Nguyen; Alka Agrawal; Ashot Papoyan; Yelena Bisharyan; Joanna Cardarelli; Donna Cassidy-Hanley; Ted Clark; Darlene Pedersen; Yasmina Abdiche; William Harriman; Bas van der Woning; Hans de Haard; Ellen Collarini; Heike Wulff; Paul Colussi
Journal:  MAbs       Date:  2018-04-02       Impact factor: 5.857

5.  Glucagon Receptor Signaling and Lipid Metabolism.

Authors:  Katrine D Galsgaard; Jens Pedersen; Filip K Knop; Jens J Holst; Nicolai J Wewer Albrechtsen
Journal:  Front Physiol       Date:  2019-04-24       Impact factor: 4.566

6.  Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies.

Authors:  Martin J Scott; Amanda Jowett; Martin Orecchia; Peter Ertl; Larissa Ouro-Gnao; Julia Ticehurst; David Gower; John Yates; Katie Poulton; Carol Harris; Michael J Mullin; Kathrine J Smith; Alan P Lewis; Nick Barton; Michael L Washburn; Ruud de Wildt
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

7.  A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation.

Authors:  Thomas Eden; Stephan Menzel; Janusz Wesolowski; Philine Bergmann; Marion Nissen; Gudrun Dubberke; Fabienne Seyfried; Birte Albrecht; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Front Immunol       Date:  2018-01-23       Impact factor: 7.561

Review 8.  Phage Display Libraries for Antibody Therapeutic Discovery and Development.

Authors:  Juan C Almagro; Martha Pedraza-Escalona; Hugo Iván Arrieta; Sonia Mayra Pérez-Tapia
Journal:  Antibodies (Basel)       Date:  2019-08-23

Review 9.  Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies.

Authors:  Man-Seok Ju; Sang Taek Jung
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.